Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002477890 | SCV002789170 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-08 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001700823 | SCV004225862 | uncertain significance | not provided | 2022-02-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700823 | SCV001926122 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700823 | SCV001973907 | uncertain significance | not provided | no assertion criteria provided | clinical testing |